In order to serve patients of all ages having lifelong bone-and-joint health needs, the company is providing minimally invasive surgical, and non-surgical products for the spine, orthopedics, and sports medicine.

Biologics president Michael Finegan said they are proud to announce the launch of Collage, their new synthetic platform based on highly-purified biocompatible materials of ß-TCP and type-1 collagen.

"We have been successful with Trinity Evolution and can now focus on broadening our portfolio of biologic products so that we can fulfill all the needs of our customers," Finegan said.